- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01055132
Dispensing Evaluation of New Daily Disposable Toric Soft Contact Lens.
June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
The purpose of this study is to determine the relative performance of a new daily disposable toric soft contact lens against a daily disposable toric contact lens currently available in market, specifically with regards to the comfort and vision with the lens.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90049
-
-
Florida
-
Jacksonville, Florida, United States, 32205
-
Jacksonville, Florida, United States, 32256
-
-
Georgia
-
Marietta, Georgia, United States, 30060
-
-
New York
-
New York, New York, United States, 10001
-
-
Rhode Island
-
Warwick, Rhode Island, United States, 02886
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The subject must be between 18 and 40 years old.
- The subject must have normal eyes.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a copy of the form.
- The subject must have a subjective distance spectacle prescription in the range of -1.75 to -5.00D in each eye.
- The subject must manifest -1.25 to -2.00 D of refractive astigmatism in each eye.
- The subject's refractive cylinder axis must be 180 degrees plus or minus 30 degrees in each eye.
- The subject must be an adapted wearer of soft toric contact lenses in both eyes.
- The subject's best visual acuity (BVA) must be better than or equal to 20/25 in each eye.
- Subjects must already possess a wearable pair of spectacles.
Exclusion Criteria:
- Ocular or systemic allergies or disease that may interfere with contact lens wear.
- Systemic disease or autoimmune disease or use of medication, which may interfere with contact lens wear.
- Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear.
- Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with contact lens wear.
- Any ocular infection.
- Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
- Pregnancy or lactation
- Any infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
- Diabetes
- Strabismus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Etafilcon A toric contact lens/Nelfilcon A toric
Etafilcon A toric contact lens first, then nelfilcon A toric second
|
contact lens to correct astigmatism
contact lens to correct astigmatism
|
|
Other: Nelfilcon A toric/ Etafilcon A toric
Nelfilcon A toric contact lens first, then etafilcon A toric toric second
|
contact lens to correct astigmatism
contact lens to correct astigmatism
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Monocular Visual Acuity on LogMAR Scale
Time Frame: After 5 to 9 days of lens wear
|
Distance (4 meter) high contrast standard resolution (ETDRS) acuity was measured twice for each eye.
Visual acuity describes the acuteness or sharpness of vision; the ability to perceive small details.
Visual acuity is a measure of spacial resolution of the visual processing system; it's tested by requiring the person being tested to identify characters (like letters and numbers)on a chart from a set distance.
LogMAR charts are used to assess visual acuity for research studies.
LogMAR means Minimum Angle of Resolution.
This has lead to the assertion that research is done using a logarithmic progression in size of letters on a test chart gives the most accurate visual acuity measurement.
The reason for this is, unlike other charts, LogMAR chart has equal gradation between the letters on the line and the space between the lines.
And, there is a fixed number of letters per line.
|
After 5 to 9 days of lens wear
|
|
Binocular Visual Acuity on LogMAR Scale
Time Frame: After 5 to 9 days of lens wear
|
Distance (4 meter) high contrast standard resolution (ETDRS) acuity was measured twice binocularly.
Distance (4 meter) high contrast standard resolution (ETDRS) acuity was measured twice for each eye.
Visual acuity describes the acuteness or sharpness of vision; the ability to perceive small details.
Visual acuity is a measure of spacial resolution of the visual processing system; it's tested by requiring the person being tested to identify characters (like letters and numbers)on a chart from a set distance.
LogMAR charts are used to assess visual acuity for research studies.
LogMAR means Minimum Angle of Resolution.
This has lead to the assertion that research is done using a logarithmic progression in size of letters on a test chart gives the most accurate visual acuity measurement.
The reason for this is, unlike other charts, LogMAR chart has equal gradation between the letters on the line and the space between the lines.
And, there is a fixed number of letters per line.
|
After 5 to 9 days of lens wear
|
|
Subject Reported Overall Lens Comfort Using the Contact Lens User Evaluation (CLUE)TM Questionnaire
Time Frame: After 5 to 9 days of lens wear
|
The Contact Lens User Evaluation(CLUE)TM questionnaire is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65.
Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.
97% of the scores fall within 0 and 120 (mean +/-3*SD).
|
After 5 to 9 days of lens wear
|
|
Subject Reported Overall Quality of Vision Using the Contact Lens User Evaluation(CLUE)TM Questionnaire.
Time Frame: After 5 to 9 days of lens wear
|
The Contact Lens User Evaluation(CLUE)TM questionnaire is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65.
Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.
97% of the scores fall within 0 and 120 (mean +/-3*SD).
|
After 5 to 9 days of lens wear
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
February 1, 2010
Study Completion (Actual)
February 1, 2010
Study Registration Dates
First Submitted
January 22, 2010
First Submitted That Met QC Criteria
January 22, 2010
First Posted (Estimate)
January 25, 2010
Study Record Updates
Last Update Posted (Actual)
June 19, 2018
Last Update Submitted That Met QC Criteria
June 18, 2018
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR-1476AG
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Bausch & Lomb IncorporatedCompleted
-
CooperVision, Inc.CompletedAstigmatism BilateralCanada
-
University Clinic FrankfurtCompleted
Clinical Trials on Etafilcon A toric contact lens
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Foresight Regulatory Strategies, Inc.Completed
-
CooperVision, Inc.CompletedAstigmatismCanada, United States
-
Alcon ResearchCompletedRefractive Error | Astigmatism | Myopia
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismAustralia, United States
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed